CardioGenics Holdings Inc (OTCMKTS:CGNH – Get Free Report) shares crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.00 and traded as high as $0.00. CardioGenics shares last traded at $0.00, with a volume of 0 shares changing hands.
CardioGenics Stock Down 100.0 %
CardioGenics Company Profile
CardioGenics Holdings Inc engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories.
Read More
- Five stocks we like better than CardioGenics
- 10 Best Airline Stocks to Buy
- Power Up: Gaming Industry Expansion Fuels Stock Opportunities
- How to Find Undervalued Stocks
- These 3 Quirky ETFs May Be Strong Plays in 2025
- How is Compound Interest Calculated?
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
Receive News & Ratings for CardioGenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CardioGenics and related companies with MarketBeat.com's FREE daily email newsletter.
